{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:24:25Z","timestamp":1789179865545,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":50,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031972966","type":"print"},{"value":"9783031972973","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-97297-3_14","type":"book-chapter","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:08:25Z","timestamp":1761325705000},"page":"165-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a Manufacturing Process for Clinical\u00a0Autologous hiPSC-Derived Retinal\u00a0Pigment\u00a0Epithelium"],"prefix":"10.1007","author":[{"given":"Shekhar","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roba","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmila","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"2","key":"14_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106\u201316.","journal-title":"Lancet Glob Health"},{"issue":"9827","key":"14_CR2","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):1728\u201338.","journal-title":"Lancet"},{"issue":"4","key":"14_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris 3rd","year":"2013","unstructured":"Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120(4):844\u201351.","journal-title":"Ophthalmology"},{"issue":"5","key":"14_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/mi.10.5.4","volume":"10","author":"Y Chen","year":"2010","unstructured":"Chen Y, Bedell M, Zhang K. Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv. 2010;10(5):271\u201381.","journal-title":"Mol Interv"},{"issue":"2","key":"14_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, et al. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology. 2020;127(2):186\u201395.","journal-title":"Ophthalmology"},{"issue":"4","key":"14_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe GJ, Westby K, Csaky KG, Mon\u00e9s J, Pearlman JA, Patel SS, et al. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial. Ophthalmology. 2021;128(4):576\u201386.","journal-title":"Ophthalmology"},{"issue":"10411","key":"14_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023;402(10411):1449\u201358.","journal-title":"Lancet"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.12.004","volume":"40","author":"L Sobrin","year":"2014","unstructured":"Sobrin L, Seddon JM. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res. 2014;40:1\u201315.","journal-title":"Prog Retin Eye Res"},{"issue":"19","key":"14_CR9","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","author":"Age-Related Eye Disease Study 2 Research G","year":"2013","unstructured":"Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005\u201315.","journal-title":"JAMA"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1146\/annurev-pharmtox-010919-023245","volume":"60","author":"R Sharma","year":"2020","unstructured":"Sharma R, Bose D, Maminishkis A, Bharti K. Retinal pigment epithelium replacement therapy for age-related macular degeneration: are we there yet? Annu Rev Pharmacol Toxicol. 2020;60:553\u201372.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"14_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"36","author":"L da Cruz","year":"2018","unstructured":"da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol. 2018;36(4):328\u201337.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"14_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.stemcr.2022.01.001","volume":"17","author":"AH Kashani","year":"2022","unstructured":"Kashani AH, Lebkowski JS, Hinton DR, Zhu D, Faynus MA, Chen S, et al. Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration. Stem Cell Rep. 2022;17(3):448\u201358.","journal-title":"Stem Cell Rep"},{"issue":"435","key":"14_CR13","doi-asserted-by":"publisher","first-page":"eaao4097","DOI":"10.1126\/scitranslmed.aao4097","volume":"10","author":"AH Kashani","year":"2018","unstructured":"Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, et al. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci Transl Med. 2018;10(435):eaao4097.","journal-title":"Sci Transl Med"},{"issue":"11","key":"14_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017;376(11):1038\u201346.","journal-title":"N Engl J Med"},{"issue":"9967","key":"14_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies. Lancet. 2015;385(9967):509\u201316.","journal-title":"Lancet"},{"issue":"5","key":"14_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.stemcr.2015.04.005","volume":"4","author":"WK Song","year":"2015","unstructured":"Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY, et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Rep. 2015;4(5):860\u201372.","journal-title":"Stem Cell Rep"},{"issue":"1","key":"14_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajo.2011.06.007","volume":"153","author":"EJ van Zeeburg","year":"2012","unstructured":"van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol. 2012;153(1):120\u20137 e2.","journal-title":"Am J Ophthalmol"},{"issue":"475","key":"14_CR18","doi-asserted-by":"publisher","first-page":"eaat5580","DOI":"10.1126\/scitranslmed.aat5580","volume":"11","author":"R Sharma","year":"2019","unstructured":"Sharma R, Khristov V, Rising A, Jha BS, Dejene R, Hotaling N, et al. Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs. Sci Transl Med. 2019;11(475):eaat5580.","journal-title":"Sci Transl Med"},{"issue":"10","key":"14_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.10.10.13","volume":"10","author":"AH Kashani","year":"2021","unstructured":"Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Chen S, et al. One-year follow-up in a phase 1\/2a clinical trial of an allogeneic RPE cell bioengineered implant for advanced dry age-related macular degeneration. Transl Vis Sci Technol. 2021;10(10):13.","journal-title":"Transl Vis Sci Technol"},{"issue":"7","key":"14_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tins.2013.03.006","volume":"36","author":"AJ Carr","year":"2013","unstructured":"Carr AJ, Smart MJ, Ramsden CM, Powner MB, da Cruz L, Coffey PJ. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 2013;36(7):385\u201395.","journal-title":"Trends Neurosci"},{"issue":"2","key":"14_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stemcr.2013.12.007","volume":"2","author":"H Kamao","year":"2014","unstructured":"Kamao H, Mandai M, Okamoto S, Sakai N, Suga A, Sugita S, et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014;2(2):205\u201318.","journal-title":"Stem Cell Rep"},{"issue":"2","key":"14_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10384-022-00974-5","volume":"67","author":"R Akiba","year":"2023","unstructured":"Akiba R, Takahashi M, Baba T, Mandai M. Progress of iPS cell-based transplantation therapy for retinal diseases. Jpn J Ophthalmol. 2023;67(2):119\u201328.","journal-title":"Jpn J Ophthalmol"},{"key":"14_CR23","unstructured":"A phase I\/IIa trial for autologous transplantation of induced pluripotent stem cell-derived retinal pigment epithelium for geographic atrophy associated with age-related macular degeneration [Internet]. 2020. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04339764."},{"issue":"5","key":"14_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1600-0749.2006.00318.x","volume":"19","author":"K Bharti","year":"2006","unstructured":"Bharti K, Nguyen MT, Skuntz S, Bertuzzi S, Arnheiter H. The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye. Pigment Cell Res. 2006;19(5):380\u201394.","journal-title":"Pigment Cell Res"},{"issue":"6858","key":"14_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/35101682","volume":"413","author":"C Niehrs","year":"2001","unstructured":"Niehrs C. Developmental biology. Solving a sticky problem. Nature. 2001;413(6858):787\u20138.","journal-title":"Nature"},{"issue":"18","key":"14_CR26","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1101\/gad.269103","volume":"17","author":"I del Barco Barrantes","year":"2003","unstructured":"del Barco Barrantes I, Davidson G, Gr\u00f6ne HJ, Westphal H, Niehrs C. Dkk1 and noggin cooperate in mammalian head induction. Genes Dev. 2003;17(18):2239\u201344.","journal-title":"Genes Dev"},{"issue":"22","key":"14_CR27","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1242\/dev.02592","volume":"133","author":"P Bovolenta","year":"2006","unstructured":"Bovolenta P, Rodriguez J, Esteve P. Frizzled\/RYK mediated signalling in axon guidance. Development. 2006;133(22):4399\u2013408.","journal-title":"Development"},{"issue":"2","key":"14_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ydbio.2006.10.011","volume":"302","author":"AM Rorick","year":"2007","unstructured":"Rorick AM, Mei W, Liette NL, Phiel C, El-Hodiri HM, Yang J. PP2A:B56epsilon is required for eye induction and eye field separation. Dev Biol. 2007;302(2):477\u201393.","journal-title":"Dev Biol"},{"issue":"16","key":"14_CR29","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1242\/dev.127.16.3581","volume":"127","author":"M Nguyen","year":"2000","unstructured":"Nguyen M, Arnheiter H. Signaling and transcriptional regulation in early mammalian eye development: a link between FGF and MITF. Development. 2000;127(16):3581\u201391.","journal-title":"Development"},{"issue":"1","key":"14_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1242\/dev.01571","volume":"132","author":"DJ Horsford","year":"2005","unstructured":"Horsford DJ, Nguyen MT, Sellar GC, Kothary R, Arnheiter H, McInnes RR. Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity. Development. 2005;132(1):177\u201387.","journal-title":"Development"},{"issue":"21","key":"14_CR31","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1242\/dev.127.21.4599","volume":"127","author":"S Fuhrmann","year":"2000","unstructured":"Fuhrmann S, Levine EM, Reh TA. Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick. Development. 2000;127(21):4599\u2013609.","journal-title":"Development"},{"issue":"15","key":"14_CR32","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1242\/dev.032136","volume":"136","author":"P Westenskow","year":"2009","unstructured":"Westenskow P, Piccolo S, Fuhrmann S. Beta-catenin controls differentiation of the retinal pigment epithelium in the mouse optic cup by regulating Mitf and Otx2 expression. Development. 2009;136(15):2505\u201310.","journal-title":"Development"},{"issue":"1","key":"14_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.celrep.2017.12.038","volume":"22","author":"HL May-Simera","year":"2018","unstructured":"May-Simera HL, Wan Q, Jha BS, Hartford J, Khristov V, Dejene R, et al. Primary cilium-mediated retinal pigment epithelium maturation is disrupted in ciliopathy patient cells. Cell Rep. 2018;22(1):189\u2013205.","journal-title":"Cell Rep"},{"issue":"3","key":"14_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101582","volume":"3","author":"R Sharma","year":"2022","unstructured":"Sharma R, Bose D, Montford J, Ortolan D, Bharti K. Triphasic developmentally guided protocol to generate retinal pigment epithelium from induced pluripotent stem cells. STAR Protoc. 2022;3(3):101582.","journal-title":"STAR Protoc"},{"issue":"4","key":"14_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.stem.2009.07.002","volume":"5","author":"M Idelson","year":"2009","unstructured":"Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N, et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell. 2009;5(4):396\u2013408.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"14_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/clo.2004.6.217","volume":"6","author":"I Klimanskaya","year":"2004","unstructured":"Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells. 2004;6(3):217\u201345.","journal-title":"Cloning Stem Cells"},{"issue":"34","key":"14_CR37","doi-asserted-by":"publisher","first-page":"12769","DOI":"10.1073\/pnas.0601990103","volume":"103","author":"DA Lamba","year":"2006","unstructured":"Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA. 2006;103(34):12769\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"14_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1167\/iovs.14-15835","volume":"56","author":"LL Leach","year":"2015","unstructured":"Leach LL, Buchholz DE, Nadar VP, Lowenstein SE, Clegg DO. Canonical\/beta-catenin Wnt pathway activation improves retinal pigmented epithelium derivation from human embryonic stem cells. Invest Ophthalmol Vis Sci. 2015;56(2):1002\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"14_CR39","unstructured":"StemCell Technologies. Ancillary material qualification: where to begin? StemCell; 2019. Available from: https:\/\/www.stemcell.com\/ancillary-material-qualification.html."},{"key":"14_CR40","unstructured":"ThermoFisher Scientific. Gibco cell therapy systems (CTS). ThermoFisher Scientific. Available from: https:\/\/www.thermofisher.com\/us\/en\/home\/clinical\/cell-gene-therapy\/cell-therapy\/cell-therapy-systems.html."},{"key":"14_CR41","unstructured":"Zdravkovi\u0107 \u0110. Cell and gene therapy products: ancillary materials and their qualification. Kvalito; 2023. Available from: https:\/\/kvalito.ch\/cell-and-gene-therapy-products-ancillary-materials-and-their-qualification\/."},{"key":"14_CR42","volume-title":"Current good manufacturing practice (CGMP) regulations","author":"U.S. Food & Drug Administration","year":"2023","unstructured":"U.S. Food & Drug Administration. Current good manufacturing practice (CGMP) regulations. U.S. Food & Drug Administration; 2023."},{"key":"14_CR43","volume-title":"EU guidelines for good manufacturing practice for medicinal products for human and veterinary use: qualification and validation","author":"European Commission","year":"2015","unstructured":"European Commission. EU guidelines for good manufacturing practice for medicinal products for human and veterinary use: qualification and validation. European Commission; 2015."},{"key":"14_CR44","unstructured":"ISPE. ISPE good practice guide: maintenance: ISPE; 2021."},{"key":"14_CR45","volume-title":"Sterile drug products produced by aseptic processing \u2014 current good manufacturing practice","author":"U.S. Food & Drug Administration","year":"2020","unstructured":"U.S. Food & Drug Administration. Sterile drug products produced by aseptic processing \u2014 current good manufacturing practice. U.S. Food & Drug Administration; 2020."},{"issue":"4","key":"14_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"4","key":"14_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.stemcr.2015.08.015","volume":"5","author":"BA Baghbaderani","year":"2015","unstructured":"Baghbaderani BA, Tian X, Neo BH, Burkall A, Dimezzo T, Sierra G, et al. cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications. Stem Cell Rep. 2015;5(4):647\u201359.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"14_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb2742","volume":"15","author":"A Radzisheuskaya","year":"2013","unstructured":"Radzisheuskaya A, Chia Gle B, dos Santos RL, Theunissen TW, Castro LF, Nichols J, et al. A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat Cell Biol. 2013;15(6):579\u201390.","journal-title":"Nat Cell Biol"},{"key":"14_CR49","unstructured":"National Institutes of Health. Regulatory toolbox: IND maintenance 2023. Available from: https:\/\/www.cc.nih.gov\/orcs\/ind5.html."},{"key":"14_CR50","unstructured":"U.S. Food & Drug Administration. Investigational new drug (IND) application: U.S. Food & Drug Administration; 2022. Available from: https:\/\/www.fda.gov\/drugs\/types-applications\/investigational-new-drug-ind-application."}],"container-title":["Advances in Experimental Medicine and Biology","Cell Therapy Manufacturing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-97297-3_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:07:20Z","timestamp":1784207240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-97297-3_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031972966","9783031972973"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-97297-3_14","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"25 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}